| P2093 | author name string | H Rozemuller | |
| | P A Doevendans | |
| | J P G Sluijter | |
| | H J Bühring | |
| | W A Noort | |
| | A C Martens | |
| | B Naaijkens | |
| | D Feyen | |
| | D Stecher | |
| | M I F J Oerlemans | |
| | S Jaksani | |
| P2860 | cites work | CD34 expression by stromal precursors in normal human adult bone marrow | Q67704482 |
| | Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects | Q74341231 |
| | Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies | Q74505218 |
| | Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute myocardial infarction with subsequent reperfusion | Q79757677 |
| | Novel markers for the prospective isolation of human MSC | Q80065230 |
| | Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo | Q80112117 |
| | Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 |
| | Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow | Q81330304 |
| | Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium | Q81845589 |
| | Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody | Q82307930 |
| | Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies | Q84002204 |
| | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester | Q28248444 |
| | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 |
| | Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice | Q30165266 |
| | Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis | Q33285990 |
| | Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 |
| | Active Wnt signaling in response to cardiac injury | Q34044380 |
| | Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. | Q34178870 |
| | Mesenchymal stem cells and cardiac repair. | Q35862434 |
| | Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine | Q35889077 |
| | Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. | Q37082699 |
| | Stem-cell therapy for cardiac disease | Q37089732 |
| | Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction | Q37294044 |
| | Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial | Q38381605 |
| | Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. | Q40195961 |
| | Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells | Q40683288 |
| | Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis | Q40746983 |
| | Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. | Q41675626 |
| | Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells | Q41836901 |
| | Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis | Q41940674 |
| | Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. | Q44229341 |
| | Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation | Q44746492 |
| | Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. | Q45859658 |
| | Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential | Q45869862 |
| | Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells | Q46181106 |
| | Preliminary characterization of porcine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor | Q46296010 |
| | Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. | Q46420592 |
| | Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction | Q46428691 |
| | Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart | Q47297920 |
| | Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. | Q50660744 |
| | Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. | Q51067770 |
| | Human mesenchymal stem cells promote survival of T cells in a quiescent state. | Q52578076 |
| | Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. | Q52958543 |
| | Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. | Q53511836 |
| | Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium | Q59196002 |
| | Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart | Q64379356 |
| P433 | issue | 8 | |
| P304 | page(s) | 1827-1839 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation | |
| P478 | volume | 16 | |